New Delhi: The Indian Council of Medical Research Director General Dr Rajiv Bahl on Monday criticised a recently published study on the long-term safety analysis of the Covaxin in adults and adolescents for its poor methodology and design, and clarified the article misleadingly and erroneously "acknowledges" ICMR. A research paper, titled 'Long-Term Safety Analysis of the BBVl52 Coronavirus Vaccine in …
The country’s apex biomedical research regulator, the Indian Council of Medical Research, has distanced itself from a Banaras Hindu University study that raised concerns on safety of Bharat Biotech’s Covid vaccine, Covaxin, and threatened legal action against the study’s authors for acknowledging ICMR’s support for a poorly designed study without its consent. ICMR chief Rajiv Bahl has formally written to …
